研究

Shinto E, Hida J, Kobayashi H, Hashiguchi Y, Hase K, Ueno H, Watanabe T, Sugihara K.

Prominent information of jN3-positive in Stage III colorectal cancer removed by D3 dissection: Retrospective analysis of 6866 patients from a multi-institutional database in Japan.

Okuno K, Aoyama T, Oba T, Yokoyama N, Matsuhashi, Kunieda K, Nishimur Y, Akamatsu H, Kobatake T, Morita S, Yoshikawa T, Sakamoto J, Saji S

Randomized phase III trial comparing surgery alone to UFT + PSK for stage II rectal cancer (JFMC38 trial)

Pagès F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, Lugli A, Zlobec I, Rau TT, Berger MD, Nagtegaal ID, Vink-Börger E, Hartmann A, Geppert C, Kolwelter J, Merkel S, Grützmann R, Van den Eynde M, Jouret-Mourin A, Kartheuser A, Léonard D, Remue C, Wang JY, Bavi P, Roehrl MHA, Ohashi PS, Nguyen LT, Han S, MacGregor HL, Hafezi-Bakhtiari S, Wouters BG, Masucci GV, Andersson EK, Zavadova E, Vocka M, Spacek J, Petruzelka L, Konopasek B, Dundr P, Skalova H, Nemejcova K, Botti G, Tatangelo F, Delrio P, Ciliberto G, Maio M, Laghi L, Grizzi F, Fredriksen T, Buttard B, Angelova M, Vasaturo A, Maby P, Church SE, Angell HK, Lafontaine L, Bruni D, El Sissy C, Haicheur N, Kirilovsky A, Berger A, Lagorce C, Meyers JP, Paustian C, Feng Z, Ballesteros-Merino C, Dijkstra J, van de Water C, van Lent-van Vliet S, Knijn N, Mușină AM, Scripcariu DV, Popivanova B, Xu M, Fujita T, Hazama S, Suzuki N, Nagano H, Okuno K, Torigoe T, Sato N, Furuhata T, Takemasa I, Itoh K, Patel PS, Vora HH, Shah B, Patel JB, Rajvik KN, Pandya SJ, Shukla SN, Wang Y, Zhang G, Kawakami Y, Marincola FM, Ascierto PA, Sargent DJ, Fox BA, Galon J

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

Kanekiyo S, Hazama S, Takenouchi H, Nakajima M, Shindo Y, Matsui H, Tokumitsu Y, Tomochika S, Tsunedomi R, Tokuhisa Y, Iida M, Sakamoto K, Suzuki N, Takeda S, Yamamoto S, Yoshino S, Okuno K, Udaka K, Kawakami Y, Matsueda S, Ito K, Nagano H.

IgG response to MHC class I epitope peptides is a quantitative predictive biomarker in the early course of treatment of colorectal cancer using therapeutic peptides

Shinto E, Hida J, Kobayashi H, Hashiguchi Y, Hase K, Ueno H, Watanabe T, Sugihara K

Prominent information of jN3-positive in Stage III colorectal cancer removed by D3 dissection: Retrospective analysis of 6866 patients from a multi-institutional database in Japan

Shinto E, Hida J, Ike H, Kobayashi H, Hashiguchi Y, Hase K, Ueno H, Sugihara K

A new N staging system for colorectal cancer in the era of extended lymphadenectomy

Tachibana I, Nishimura Y, Inada M, Fukuda K, Ishikawa K, Nishikawa T, Yokokawa M, Nakamatsu K, Kanamori S, Hida J

Definitive chemoradiotherapy for anal canal cancer: single-center experience

Kawamura J, Ueda K, Ushijima H, Daito K, Okuno K.

Transanal minimally invasive approach for the resection of retrorectal tumour - a video vignette

Kawamura J, Sugiura F, Sukegawa Y, Yoshioka Y, Hida JI, Hazama S, Okuno K

Multicenter, phase II clinical trial of peptide vaccination with oral chemotherapy following curative resection for stage III colorectal cancer

Kawamura J, Sugiura F, Sukegawa Y, Yoshioka Y, Hida JI, Hazama S, Okuno K

Cytotoxic T lymphocyte response to peptide vaccination predicts survival in stage III colorectal cancer